These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3435327)

  • 1. Bromocriptine in mild to moderate hypertension.
    Whitworth JA; Macdonald I; Kincaid-Smith P
    Aust N Z J Med; 1987 Aug; 17(4):457-8. PubMed ID: 3435327
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Bromocriptine and hypertension.
    Kaye SB; Shaw KM; Ross EJ
    Lancet; 1976 May; 1(7970):1176-7. PubMed ID: 58213
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of bromocriptine in methyldopa treated hypertension.
    Lewis MJ; Henderson AH
    Br J Clin Pharmacol; 1980 Jan; 9(1):57-60. PubMed ID: 6986893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of bromocriptine on arterial blood pressure and serum prolactin level in patients with essential arterial hypertension].
    Hudziak G; Kuska J
    Kardiol Pol; 1988; 31 Suppl 1():22-9. PubMed ID: 3221620
    [No Abstract]   [Full Text] [Related]  

  • 5. The patient with mild to moderate essential hypertension: peripheral renin activity and a comparative drug study.
    Merkle GW; Bader PI; Creason PL; Townsend DW; Conn PS; Lakes MK; Campbell NM
    J Indiana State Med Assoc; 1981 Jul; 74(7):444-9. PubMed ID: 7024422
    [No Abstract]   [Full Text] [Related]  

  • 6. Bromocriptine in hypertension.
    Lewis MJ
    Br J Hosp Med; 1978 Dec; 20(6):661-5. PubMed ID: 743579
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic effect of bromocriptine together with the established treatment for hypertension in patients undergoing peritoneal dialysis.
    Mejía-Rodríguez O; Alvarez-Aguilar C; Ledesma-Ramírez M; Paniagua-Sierra R
    Proc West Pharmacol Soc; 2004; 47():122-4. PubMed ID: 15633631
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of combined treatment with dopamine receptor agonists and antagonists of aldosterone on the performance of daily blood pressure monitoring in patients with hypertension and concomitant obesity].
    Lyzogub VG; Sobol' VO; Dolynna OV; Kuz'mins'ka LA
    Lik Sprava; 2012; (1-2):63-8. PubMed ID: 23035601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypotensive action of a dopaminergic agonist, bromocriptine, in the dog].
    Montastruc JL; Rascol A; Montastruc P
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():91-8. PubMed ID: 6794532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control.
    Stumpe KO; Kolloch R; Higuchi M; Krück F; Vetter H
    Lancet; 1977 Jul; 2(8031):211-4. PubMed ID: 69827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the antihypertensive effects of furosemide and chlorothiazide.
    Bariso CR; Hanenson IB; Gaffney TE
    Curr Ther Res Clin Exp; 1970 Jun; 12(6):333-40. PubMed ID: 4987341
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of bromocriptine treatment on prolactin, noradrenaline and blood pressure in hypertensive haemodialysis patients.
    Degli Esposti E; Sturani A; Santoro A; Zuccalà A; Chiarini C; Zucchelli P
    Clin Sci (Lond); 1985 Jul; 69(1):51-6. PubMed ID: 3905210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazides and blood pressure.
    Jones B; Nanra RS
    Lancet; 1980 May; 1(8178):1135. PubMed ID: 6103464
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of bromocriptine on blood pressure and plasma beta-endorphin in spontaneously hypertensive rats.
    Hutchinson JS; Di Nicolantonio R; Lim A; Clements J; Funder JW
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():343s-345s. PubMed ID: 6274577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of experimental hypertension in rats by prolonged administration of a combination of antihypertensive agents].
    Ghaye-Roquet J; Jousse S; Ganter P
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):14-22. PubMed ID: 5111321
    [No Abstract]   [Full Text] [Related]  

  • 16. Parkinson's disease and hypertension: chronic bromocriptine treatment.
    Montastruc JL; Chamontin B; Rascol A
    Neurology; 1985 Nov; 35(11):1644-7. PubMed ID: 4058753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of furosemide and chlorothiazide on blood pressure and plasma renin activity.
    Saito I; Misumi J; Kondo K; Saruta T; Matsuki S
    Cardiovasc Res; 1976 Mar; 10(2):149-52. PubMed ID: 938983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of intra-venous diazoxide, a non-diuretic thiazide, upon blood pressure, electrolyte, and uric acid excretion.
    Thompson GR; Anderson RW; Ballantyne LM
    Mich Med; 1966 Jan; 65(1):17-21. PubMed ID: 5900922
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of chlorothiazide on serial measurements of exchangeable sodium and blood pressure in spontaneously hypertensive rats.
    Manhem PJ; Clark SA; Brown WB; Murray GD; Robertson JI
    Clin Sci (Lond); 1985 Nov; 69(5):511-5. PubMed ID: 4053506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How do we explain the antihypertensive effect of bromocriptine? Clinical and experimental contribution].
    Chamontin B; Montastruc JL; Rascol A
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1181-5. PubMed ID: 6151826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.